Conserved residues of tumour necrosis factor and lymphotoxin constitute the framework of the trimeric structure

[1]  D. I. Stuart,et al.  Structure of tumour necrosis factor , 1989, Nature.

[2]  S. Sprang,et al.  Crystallization of trimeric recombinant human tumor necrosis factor (cachectin). , 1988, The Journal of biological chemistry.

[3]  T. Prangé,et al.  Structure of tumour necrosis factor by X-ray solution scattering and preliminary studies by single crystal X-ray diffraction. , 1988, Journal of molecular biology.

[4]  V. Garsky,et al.  Antibodies against amino acids 1-15 of tumor necrosis factor block its binding to cell-surface receptor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[5]  T. Arakawa,et al.  Role of single disulfide in recombinant human tumor necrosis factor-alpha. , 1987, The Journal of biological chemistry.

[6]  P. Gray,et al.  The murine tumor necrosis factor-beta (lymphotoxin) gene sequence. , 1987, Nucleic acids research.

[7]  J. Tavernier,et al.  Molecular cloning and expression of human tumor necrosis factor and comparison with mouse tumor necrosis factor. , 1985, European journal of biochemistry.

[8]  J. Tavernier,et al.  Molecular cloning of mouse tumour necrosis factor cDNA and its eukaryotic expression. , 1985, Nucleic acids research.

[9]  B. Aggarwal,et al.  Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity , 1984, Nature.

[10]  S. Wodak,et al.  Modelling the polypeptide backbone with 'spare parts' from known protein structures. , 1989, Protein engineering.

[11]  J. Tavernier,et al.  Lymphokines and monokines in anti-cancer therapy. , 1986, Cold Spring Harbor symposia on quantitative biology.